Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

541.89
+60.4212.55%
Pre-market: 541.00-0.8900-0.16%04:20 EDT
Volume:3.34M
Turnover:1.79B
Market Cap:23.24B
PE:19.39
High:557.37
Open:482.20
Low:475.46
Close:481.47
52wk High:609.35
52wk Low:409.07
Shares:42.89M
Float Shares:39.35M
Volume Ratio:6.52
T/O Rate:8.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.63
PE(LYR):19.45

Loading ...

United Therapeutics Acquires Thymmune Therapeutics for USD 140 Million Upfront

Reuters
·
Jul 02

United Therapeutics Corp - Deal Valued at $140 Mln Cash Plus up to $160 Mln in Earn-outs by 2031

THOMSON REUTERS
·
Jul 02

14 Value Stocks of Companies Primed for Rapid Growth Through 2028

Dow Jones
·
Jul 02

United Therapeutics CEO Martine Rothblatt Reports Disposal of 9,500 Common Shares Valued at $5.16 Million

Reuters
·
Jul 01

United Therapeutics IPF Opportunity Outweighs Base Business Risks, UBS Says

MT Newswires Live
·
Jul 01

United Therapeutics Shareholders Endorse 2026 Governance and Pay

TIPRANKS
·
Jun 30

United Therapeutics Chairperson, CEO Martine Rothblatt Disposes of 9,500 Common Shares for $5.12 Million

Reuters
·
Jun 30

United Therapeutics Shareholders Approve 2026 Stock Incentive Plan at Annual Meeting

Reuters
·
Jun 30

United Therapeutics Wins FDA Approval for Lungfx Lung Perfusion Device

Reuters
·
Jun 29

United Therapeutics Corp - Lung Bioengineering Expects to Add Lungfx to Services in 2027

THOMSON REUTERS
·
Jun 29

United Therapeutics Corporation Announces FDA Approval of the Lungfx™ Device for Centralized Ex Vivo Lung Perfusion

THOMSON REUTERS
·
Jun 29

United Therapeutics CEO Martine Rothblatt Disposes of USD 4.99 Million in Common Shares

Reuters
·
Jun 26

United Therapeutics Chairperson and CEO Martine Rothblatt Disposes of Common Shares Worth $5.08 Million

Reuters
·
Jun 24

United Therapeutics CFO James Edgemond sells 8,750 shares worth $4.7 million

Reuters
·
Jun 24

United Therapeutics CEO Martine Rothblatt disposes of 11,480 common shares worth $6.19 million

Reuters
·
Jun 23

United Therapeutics Chairperson, CEO Martine Rothblatt disposes of USD 5.19 million in common shares

Reuters
·
Jun 18

United Therapeutics CFO, Treasurer James Edgemond disposes of USD 9.12 million in common shares

Reuters
·
Jun 17

United Therapeutics Chairperson, CEO Martine Rothblatt sells $4.9 million in common shares

Reuters
·
Jun 16

United Therapeutics CFO James Edgemond disposes of common shares worth $5.42 million

Reuters
·
Jun 13

United Therapeutics Chairperson, CEO Martine Rothblatt disposes of common shares worth $5.17 million

Reuters
·
Jun 13